Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSafety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study.AuthorsHo, Ching-Liang; Chao, Tsu-Yi; Chang, Chia-Lun; Lin, Hsuan-YuPublicationBioDrugs, 2024, Vol 38, Issue 2, p287ISSN1173-8804Publication typeArticleDOI10.1007/s40259-023-00639-w